Cargando…
Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
Accurate evaluation of disease activity is essential for choosing an appropriate treatment and follow-up plan for patients with inflammatory bowel disease (IBD). Endoscopy is required for accurately evaluating disease activity, but the procedures are sometimes invasive and burdensome to patients. Th...
Autores principales: | Kato, Jun, Hiraoka, Sakiko, Nakarai, Asuka, Takashima, Shiho, Inokuchi, Toshihiro, Ichinose, Masao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754522/ https://www.ncbi.nlm.nih.gov/pubmed/26884729 http://dx.doi.org/10.5217/ir.2016.14.1.5 |
Ejemplares similares
-
Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis
por: Hiraoka, Sakiko, et al.
Publicado: (2018) -
The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces
por: Hiraoka, Sakiko, et al.
Publicado: (2019) -
Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018) -
Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019) -
An Elevated Platelet Count Increases the Risk of Relapse in Ulcerative Colitis Patients with Mucosal Healing
por: Nakarai, Asuka, et al.
Publicado: (2018)